These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 27681962)

  • 21. [Proton pump inhibitors and clopidogrel in a patient with cardiovascular risk factors: Cardiovascular versus gastrointestinal risk?].
    Lanas A
    Gastroenterol Hepatol; 2010 Jan; 33(1):1-5. PubMed ID: 20005015
    [No Abstract]   [Full Text] [Related]  

  • 22. Risk of community-acquired pneumonia in veteran patients to whom proton pump inhibitors were dispensed.
    Hermos JA; Young MM; Fonda JR; Gagnon DR; Fiore LD; Lawler EV
    Clin Infect Dis; 2012 Jan; 54(1):33-42. PubMed ID: 22100573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acid-suppressive drugs and community-acquired pneumonia.
    Rodríguez LA; Ruigómez A; Wallander MA; Johansson S
    Epidemiology; 2009 Nov; 20(6):800-6. PubMed ID: 19797970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [In process].
    Storr M
    Med Monatsschr Pharm; 2016 Sep; 39(9):391-5. PubMed ID: 29956514
    [No Abstract]   [Full Text] [Related]  

  • 25. No consistent evidence of differential cardiovascular risk amongst proton-pump inhibitors when used with clopidogrel: meta-analysis.
    Kwok CS; Jeevanantham V; Dawn B; Loke YK
    Int J Cardiol; 2013 Aug; 167(3):965-74. PubMed ID: 22464478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Meta-analysis: cyclooxygenase-2 inhibitors are no better than nonselective nonsteroidal anti-inflammatory drugs with proton pump inhibitors in regard to gastrointestinal adverse events in osteoarthritis and rheumatoid arthritis.
    Wang X; Tian HJ; Yang HK; Wanyan P; Peng YJ
    Eur J Gastroenterol Hepatol; 2011 Oct; 23(10):876-80. PubMed ID: 21900785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heartburn Meds Alter the Gut.
    Moyer MW
    Sci Am; 2016 May; 314(5):17. PubMed ID: 27100242
    [No Abstract]   [Full Text] [Related]  

  • 28. Proton pump inhibitors therapy and the risk of pneumonia: a systematic review and meta-analysis of randomized controlled trials and observational studies.
    Wang CH; Li CH; Hsieh R; Fan CY; Hsu TC; Chang WC; Hsu WT; Lin YY; Lee CC
    Expert Opin Drug Saf; 2019 Mar; 18(3):163-172. PubMed ID: 30704306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interpreting Reported Risks Associated With Use of Proton Pump Inhibitors: Residual Confounding in a 10-Year Analysis of National Ambulatory Data.
    Ma C; Shaheen AA; Congly SE; Andrews CN; Moayyedi P; Forbes N
    Gastroenterology; 2020 Feb; 158(3):780-782.e3. PubMed ID: 31678304
    [No Abstract]   [Full Text] [Related]  

  • 30. NSAID-induced gastrointestinal and cardiovascular injury.
    Ng SC; Chan FK
    Curr Opin Gastroenterol; 2010 Nov; 26(6):611-7. PubMed ID: 20948372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complications of Proton Pump Inhibitor Therapy.
    Vaezi MF; Yang YX; Howden CW
    Gastroenterology; 2017 Jul; 153(1):35-48. PubMed ID: 28528705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequency and time to onset of community-acquired respiratory tract infections in patients receiving esomeprazole: a retrospective analysis of patient-level data in placebo-controlled studies.
    Estborn L; Joelson S
    Aliment Pharmacol Ther; 2015 Sep; 42(5):607-13. PubMed ID: 26147295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Community-acquired pneumonia and acid-suppressive drugs: position statement.
    CAG Clinical Affairs Committee
    Can J Gastroenterol; 2006 Feb; 20(2):119-21, 123-5. PubMed ID: 16482239
    [No Abstract]   [Full Text] [Related]  

  • 34. A safety review of proton pump inhibitors to treat acid-related digestive diseases.
    Savarino E; Marabotto E; Zentilin P; Furnari M; Bodini G; Pellegatta G; Lorenzon G; Della Coletta M; Ghisa M; Coppo C; Marinelli C; Savarino V
    Expert Opin Drug Saf; 2018 Aug; 17(8):785-794. PubMed ID: 30035645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Considerations for the use of proton-pump inhibitors in older adults.
    Desilets AR; Asal NJ; Dunican KC
    Consult Pharm; 2012 Feb; 27(2):114-20. PubMed ID: 22330952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does treating gastroesophageal reflux cause pneumonia?
    Federico M
    J Pediatr Gastroenterol Nutr; 2005 Mar; 40(3):386-7. PubMed ID: 15735501
    [No Abstract]   [Full Text] [Related]  

  • 37. Highlights From Digestive Disease Week-Pandemic-Related Decline in Colorectal Cancer Screening, Lack of Association Between Proton Pump Inhibitors and Dementia, and More.
    Rubin R
    JAMA; 2022 Jul; 328(1):8-9. PubMed ID: 35687359
    [No Abstract]   [Full Text] [Related]  

  • 38. Proton pump inhibitor therapy predisposes to community-acquired Streptococcus pneumoniae pneumonia.
    de Jager CP; Wever PC; Gemen EF; van Oijen MG; van Gageldonk-Lafeber AB; Siersema PD; Kusters GC; Laheij RJ
    Aliment Pharmacol Ther; 2012 Nov; 36(10):941-9. PubMed ID: 23034135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adverse Events of Proton Pump Inhibitors: Potential Mechanisms.
    Corsonello A; Lattanzio F; Bustacchini S; Garasto S; Cozza A; Schepisi R; Lenci F; Luciani F; Maggio MG; Ticinesi A; Butto V; Tagliaferri S; Corica F
    Curr Drug Metab; 2018; 19(2):142-154. PubMed ID: 29219052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Community-acquired pneumonia and use of gastric acid-suppressive drugs.
    Sataloff RT
    JAMA; 2005 Feb; 293(7):795-6; author reply 796. PubMed ID: 15713765
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.